about
Lung transplantation. Donor selection.KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis.The First Experience of Ex-Vivo Lung Perfusion (EVLP) in Iran: An Effective Method to Increase Suitable Lung for Transplantation.Erroneous diagnosis of small cell lung cancer based on small biopsies with far-reaching consequences: case report of a typical carcinoid tumorRetransplantation.A rare indication for lung transplantation - pulmonary alveolar microlithiasis: institutional experience of five consecutive cases.Bronchoscopic Indocyanine Green Fluorescence Imaging of the Anastomotic Perfusion After Tracheal Surgery.Lobar lung transplantation from deceased donors: A systematic reviewRobotic thoracic surgery results in shorter hospital stay and lower postoperative pain compared to open thoracotomy: a matched pairs analysis.High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer.Intrathoracic solitary fibrous tumor - an international multicenter study on clinical outcome and novel circulating biomarkers.Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca2+ Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK.Extracorporeal membrane oxygenation support for complex tracheo-bronchial procedures†.Awake extracorporeal membrane oxygenation bridging for pulmonary retransplantation provides comparable results to elective retransplantation.Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy.Clinical ex vivo lung perfusion--pushing the limits.Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.Initial experience with oral valganciclovir for pre-emptive cytomegalovirus therapy after lung transplantation.The role of surgery in high grade neuroendocrine tumours of the lung.Pulmonary metastasectomy for sarcoma-Essen experience.Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma.Growth patterns of pulmonary metastases: should we adjust resection techniques to primary histology and size?Treatment of primary graft dysfunction after lung transplantation with orally inhaled AP301: A prospective, randomized pilot study.Standard donor lung procurement with normothermic ex vivo lung perfusion: A prospective randomized clinical trial.Donor total lung capacity predicts recipient total lung capacity after size-reduced lung transplantation.Size-reduced lung transplantation: an advanced operative strategy to alleviate donor organ shortage.Ex Vivo Lung Perfusion: Establishment and Operationalization in Iran.Reversible compression of the left lower lobe vein after right pneumonectomy.Quality of life after lung transplantation: a cross-sectional study.Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study.Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I non-small-cell lung cancer.[Resection concepts for early stage neuroendocrine tumors of the lungs and bronchi].Inhibition of radiation-induced Ccl2 signaling protects lungs from vascular dysfunction and endothelial cell loss.Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome.Same-day Routine Chest-X Ray After Thoracic Surgery is Not Necessary!Extracorporeal carbon dioxide removal as a bridge to lung transplantation in life-threatening hypercapnia.Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Low-FEV1 Patients.Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.Extracorporeal CO2 removal as bridge to lung transplantation in life-threatening hypercapnia.Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
P50
Q35293806-31CA52BA-BAB5-4236-BD06-7175F9DC5CF9Q37554470-280832B3-9150-49C2-BF7C-49C628E09C30Q37569177-5AB7260E-3D44-4252-9B87-CDBCB592CE88Q37677633-90AE47F8-52BE-4152-8D34-5E022CF5FF34Q38564364-EE097F1B-96C0-45DE-B6F4-E4E313C41271Q38721665-EDB88246-A689-472C-A8B4-E7F00EDDC032Q38903716-75843336-2B56-4B62-B7F0-601599351D1AQ38915833-D41D88F6-0AD5-4524-BD21-984E6B7EE4C4Q38919280-352C0B79-8E72-4D54-9CB2-BE28B2A399D3Q39440623-BEC3C2F9-BFE4-43EE-BD51-67177B57D6EFQ42035019-A423E893-0FC0-4AF5-8968-700187E5F323Q42248631-2CDEC5A6-5878-427A-B613-7C33C4D2862FQ44034680-406A5AB8-1C55-417D-BA67-B75B17F84A6FQ44529803-C58C62B2-8D6E-46DE-8682-A433B69E8D8DQ45949632-BA7D0829-FB7B-46BF-8A48-B164AAB46F1BQ46401873-7E0E9029-DF69-4265-8D5D-8CF676F0C312Q46435264-D570E237-85B4-45FB-8367-6158D966756FQ46643390-6E277C06-BEE7-4EB9-B3E6-869D3E86BA23Q47117731-60D9ADDB-0950-405A-84FB-E894DEFFB763Q47132298-52C191C6-3A13-416D-BFA3-5BD36D0B6094Q47133994-6771052D-6094-4021-BA88-357B418D6543Q47221245-A5078E30-D9C3-43E2-97BD-63CB17123911Q47239471-23C8565A-B2DB-4074-87F9-B337D80F4345Q47318159-3B96136D-5F60-43F2-B648-2C9DFD8C3FA5Q47356875-AA4B2230-188D-43B1-91F1-0C43AB32133AQ47396968-5029C573-10F1-4E8E-BC73-C29A1B33F5A5Q47659057-A43005E4-794B-4EB7-BAEC-6C20D80E4495Q47739758-48D6858E-A7EF-4227-941D-B76C056279F3Q47824156-EB213F72-4D24-4859-ACE3-1F7ACA416169Q48362573-675D4A95-601C-4319-A544-161EE9679BF0Q48557157-0333D097-C7D2-4034-8E69-F57913F736B9Q49502993-30246850-9350-44BA-918D-B2AECA4EBF47Q49797843-9B4C395B-A9D3-47F0-B6ED-B0FB859568EBQ49821130-61CCAB91-B31B-493F-8259-0DF42E61286CQ50109700-C3AC695E-52B1-4942-850F-B17222C1DD8AQ50199484-B66F2FCC-D454-4054-BBDE-3DC42301775CQ51420982-0F45B2BD-90E7-486D-ACC4-1BB9E864EA6CQ51509080-2BE8E03A-7B3B-453C-A0F3-05F04D7D73F4Q51684698-A48C28AE-1898-4470-B170-6ABD996F37F6Q51706711-FE8A2500-697A-4CD4-B29B-440D650B05BE
P50
description
researcher ORCID ID = 0000-0002-7787-991X
@en
wetenschapper
@nl
name
Clemens Aigner
@ast
Clemens Aigner
@en
Clemens Aigner
@es
Clemens Aigner
@nl
type
label
Clemens Aigner
@ast
Clemens Aigner
@en
Clemens Aigner
@es
Clemens Aigner
@nl
prefLabel
Clemens Aigner
@ast
Clemens Aigner
@en
Clemens Aigner
@es
Clemens Aigner
@nl
P106
P31
P496
0000-0002-7787-991X